Blackstone Inc’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.3M Sell
124,174
-36,443
-23% -$1.98M 0.02% 116
2026
Q1
$10.1M Buy
160,617
+138,416
+623% +$11.1M 0.04% 84
2025
Q4
$2.12M Buy
22,201
+14,832
+201% +$1.45M 0.01% 191
2025
Q3
$719K Buy
+7,369
New +$763K ﹤0.01% 223

Other funds holding BSX

Blackstone Inc's BSX Position: Q2 2026 in Review

Blackstone Inc reduced its Boston Scientific (BSX) stake by 23% in Q2 2026, selling an estimated $1.98M and leaving 124,174 shares worth $5.3M. The position accounts for 0.02% of the portfolio, ranked #116.

Blackstone Inc first reported a position in BSX in Q3 2025 and has held it in 4 quarters since. The position peaked at $10.1M in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Blackstone Inc held 124,174 shares of Boston Scientific worth $5.3M as of Q2 2026.
  • Blackstone Inc sold 36,443 Boston Scientific shares in Q2 2026, an estimated $1.98M.
  • Boston Scientific made up 0.02% of Blackstone Inc's portfolio in Q2 2026, its #116 holding.
  • Blackstone Inc first reported a position in Boston Scientific in Q3 2025 and has held it in 4 quarters since.
  • Blackstone Inc's Boston Scientific position peaked at $10.1M in Q1 2026.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.